10 Pro-Life Companies to Invest In Now
Investing isn’t just about numbers—it’s also about values.
Haemonetics Corp (HAE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 1,153,268 | $90,047,165 | -5% | 0.83% |
| 2. | SG Capital Management Ken Grossman And Glen Schneider | 878,804 | $68,617,016 | +37% | 6.63% |
| 3. | Fisher Asset Management Ken Fisher | 711,774 | $55,575,312 | +4% | 0.02% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 279,997 | $21,862,167 | +26% | 0.02% |
| 5. | Hood River Capital Management David Swank | 214,290 | $16,731,763 | 0.24% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $80.93 | 4,000 | Director | 12,048 | 2020-08-11 | Filing | |
| $35.00 | 60,000 | Officer | 105,867 | 2016-08-04 | Filing | |
| $32.73 | 412 | Officer | 31,522 | 2013-04-30 | Filing | |
| $32.73 | 615 | Officer | 17,279 | 2013-04-30 | Filing | |
| $32.73 | 245 | Officer | 16,751 | 2013-04-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $91.15 | 4,312 | Officer | 18,196 | 2024-07-26 | Filing | |
| $90.00 | 79 | Officer | 21,331 | 2024-07-12 | Filing | |
| $90.00 | 2,136 | Officer | 21,410 | 2024-07-11 | Filing | |
| $88.57 | 4,094 | Officer | 31,257 | 2024-05-29 | Filing | |
| $87.86 | 8,896 | Officer | 35,351 | 2024-05-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 42,722 | $2,714,983 | 0.04% | |
| 2. | 22 | $1,398 | 0% |
News See All
Haemonetics Corporation (NYSE:HAE) Q3 2025 Earnings Call Transcript
Operator: Good day, and welcome to the Haemonetics Third Quarter Fiscal Year 2025 Conference Call and Webcast. At this time, all participants are in a listen-only-mod.
Haemonetics Corporation (NYSE:HAE) Q2 2025 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Second Quarter 2025 Haemonetics Corporation Earnings Conference Call. At this time, all participants are in a listen-only mode.
Haemonetics Corporation (NYSE:HAE) Q1 2025 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to Haemonetics Corporation’s First Quarter Fiscal Year 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Haemonetics Corporation (NYSE:HAE) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q4 2024 Haemonetics Corporation Earnings Conference Call. At this time, all participants are in a listen-only mode.
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
Haemonetics Corporation (NYSE:HAE) Q3 2024 Earnings Call Transcript
Haemonetics Corporation beats earnings expectations. Reported EPS is $1.04, expectations were $0.97.
Haemonetics Corporation (NYSE:HAE) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by, and welcome to the Second Quarter 2024 Haemonetics Corporation Earnings Conference Call. At this time, all participants are in a listen-only mode.
Ken Fisher Portfolio: 15 Biggest Small-Cap Positions
In this article, we will discuss Ken Fisher portfolio: 15 biggest small-cap positions.
Haemonetics Corporation (NYSE:HAE) Q1 2024 Earnings Call Transcript
Operator: Good morning and thank you for standing by. Welcome to the First Quarter 2024 Haemonetics Corporation's Earnings Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
